Page last updated: 2024-11-11
neopine
Description
neopine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
neopine : A morphinane alkaloid that is the Delta(8,14) isomer of codeine. It is a minor constituent in opium from Papaver somniferum. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|
| Papaver | genus | A genus of Eurasian herbaceous plants, the poppies (family PAPAVERACEAE of the dicotyledon class Magnoliopsida), that yield OPIUM from the latex of the unripe seed pods.[MeSH] | Papaveraceae | The poppy plant family of the order Papaverales, subclass Magnoliidae, class Magnoliopsida. These have bisexual, regular, cup-shaped flowers with one superior pistil and many stamens; 2 or 3 conspicuous, separate sepals and a number of separate petals. The fruit is a capsule. Leaves are usually deeply cut or divided into leaflets.[MeSH] |
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 5462437 |
| CHEBI ID | 7509 |
| SCHEMBL ID | 679477 |
| MeSH ID | M0506077 |
Synonyms (24)
| Synonym |
|---|
| BRD-K34252131-001-02-0 |
| SPECTRUM5_001754 |
| BSPBIO_002761 |
| C09594 |
| 467-14-1 |
| neopine |
| KBIO3_001981 |
| KBIOGR_001657 |
| SPECTRUM2_001745 , |
| SPECTRUM3_001011 , |
| SPECTRUM4_001139 |
| SPBIO_001850 |
| unii-tm43jb0ia8 |
| (5alpha,6alpha)-8,14-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol |
| einecs 207-387-7 |
| tm43jb0ia8 , |
| CCG-39441 |
| SCHEMBL679477 |
| CHEBI:7509 |
| neopine [mi] |
| (5.alpha.,6.alpha.)-8,14-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol |
| DTXSID80196910 |
| Q27107515 |
| (4r,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,6,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinolin-7-ol |
Drug Classes (2)
| Class | Description |
|---|
| organic heteropentacyclic compound | |
| morphinane alkaloid | An isoquinoline alkaloid based on a morphinan skeleton and its substituted derivatives. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 31.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 31.15 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.59 (4.65) | | Search Engine Demand Index | 36.71 (26.88) | | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |